Quite often in the stock market, the share price of a hot company can suddenly fall out of favor, causing investors to dump the stock. The trick is to find out whether the negative sentiment is in fact warranted. If not, then this oversold stock... read more »
One of my all-time favorite investing articles talks about how important growth is when buying a stock. The author goes back in time and demonstrates that, by buying into leading growth companies, investors could garner incredible annual returns.... read more »
The world economy may be struggling to recover from the depths of the Great Recession, but there are still pockets of the market that are seeing explosive growth. Demand for electronic gadgets held up amazingly well during the credit crisis,... read more »
In the 1994 investment classic The Warren Buffett Way, author Robert Hagstrom delves into great detail on the stocks that catapulted Buffett’s fortune into what it is today. In the chapter describing Berkshire Hathaway’s primary... read more »
Back in the fall of 2010, I touted technology giant International Business Machines (NYSE: IBM) in the belief that its stock was poised to have a strong run. A key part of this bullishness was a bold prediction by its management team that it... read more »
Warren Buffett is no fan of short-term trends. Rather than focusing on the flavor of the minute, Buffett instead fixates on trends that will last decades. And then he makes a fortune off of them. Take his investment in Coca-Cola (NYSE:... read more »
Insurance giant American International Group (NYSE: AIG), or AIG for short, has had a tumultuous few years, to say the least. Right now, a handful of investors literally hate the stock and refuse to buy it. That’s their loss… As... read more »
When it comes to the stock market, many investors — myself included — spend quite a bit of time analyzing the trading activity of the richest and most successful investors in the world. These include well-known experts like Warren... read more »
Bill Ackman may not be a household name in the world of investing, but he should be. For starters, he became a billionaire through the successful management of hedge funds and by concentrating his bets into a small handful of opportunities he... read more »
A key challenge in the pharmaceutical industry these days is the staggering amount of drugs losing their patent protection. Back in November 2011, Pfizer’s (NYSE: PFE) Lipitor — the company’s all-time best-selling drug, which... read more »
LEGAL DISCLAIMER: TopStockAnalysts.com and its parent company, StreetAuthority, LLC, are publishers of financial news and opinions and NOT securities brokers/dealers or investment advisors. You are responsible for your own investment decisions. All information contained in our newsletters or on our web site(s) should be independently verified with the companies mentioned, and readers should always conduct their own research and due diligence and consider obtaining professional advice before making any investment decision. As a condition to accessing our materials and web sites, you agree to our Terms and Conditions of Use, available here, including without limitation all disclaimers of warranties and limitations on liability contained therein. Owners, employees and writers may hold positions in the securities that are discussed in our newsletters or on our web site.
TopStockAnalysts.com
4601 Spicewood Springs Rd. Building 3, Suite 100 Austin, Texas 78759 (512) 501-4002 Copyright © 2006-2011 TopStockAnalysts.com